辉瑞（中国）研究开发有限公司

On October 31 2005 Pfizer announced the official opening of ChinaResearch and Development Center (CRDC) in Shanghai. Pfizer GlobalResearch and Development’s Center is mainly engaged in drug developmentactivities. Much of the facility's capacity is devoted to the studydesign data management and statistical analysis of global phase I-IVclinical trials as well as the clinical study report process. Inaddition CRDC is a part of Pfizer global Safety and Risk Management andcovers the functions of... 查看详情 >